Eli Lilly and CompanyLLYNYSE
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+50.8%
5Y CAGR+32.7%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+50.8%/yr
vs +9.5%/yr prior
5Y CAGR
+32.7%/yr
Recent acceleration
Acceleration
+41.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.1x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $29.70B | +69.7% |
| 2024 | $17.50B | +62.2% |
| 2023 | $10.79B | +24.7% |
| 2022 | $8.65B | +9.1% |
| 2021 | $7.93B | +10.0% |
| 2020 | $7.21B | +20.2% |
| 2019 | $6.00B | -0.4% |
| 2018 | $6.03B | +41.8% |
| 2017 | $4.25B | +9.8% |
| 2016 | $3.87B | - |